Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease

American Journal of Gastroenterology

Volumn 96, Issue 9 SUPPL., 2001, Pages 2677-2682

  Papa, Alfredo ^a,b   De Stefano, Valerio ^a   Danese, Silvio ^a   Chiusolo, Patrizia ^a   Persichilli, Silvia ^a   Casorelli, Ida ^a   Zappacosta, Bruno ^a   Giardina, Bruno ^a   Gasbarrini, Antonio ^a   Leone, Giuseppe ^a   Gasbarrini, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; ENTERITIS; FEMALE; FOLIC ACID DEFICIENCY; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS;

ADULT; AGED; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE;

EID: 0034827834     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02689-2     Document Type: Article

References (47)

1. Vascular complications of inflammatory bowel disease
2. Venous thrombosis occurring in non-specific ulcerative colitis. A necropsy study
3. The course and prognosis of ulcerative colitis. Part III. Complications
4. Thrombosis in inflammatory bowel disease: Clinical setting, procoagulant profile and factor V Leiden
5. Pathogenesis of Crohn's disease: Multifocal intestinal infarction
6. Mucosal capillary thrombi in rectal biopsies
7. Inherited disorders of coagulation appear to protect against inflammatory bowel disease
8. Hyperhomocysteinemia, atherosclerosis and thrombosis
9. Mechanisms of disease: Homocysteine and atherothrombosis
10. Intermediate homocysteinaemia: A thermolabile variant of methylenetetrahydrofolate reductase
11. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
12. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
13. Prevalence of the 677C to T mutation in the methylenetetrahydrofolate reductase gene in Italian patients with venous thrombotic disease
14. Prevalence of congenital homocystinuria in Denmark
15. Newborn screening for homocystinuria: Irish and world experience
16. Disorders of transsulfuration
17. Heterozigosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease
18. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population
19. European Cooperative Crohn's Disease Study (ECCDS). Results of drug treatment
20. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial
21. Development of a Crohn's Disease Activity Index: National Cooperative Crohn's Disease Study
22. Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease
23. Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection
24. A simple salting out procedure for extracting DNA from human nucleated cells
25. High prevalence of a mutation in the cystathionine B-synthase gene
26. Inflammatory bowel disease promotes venous thrombosis earlier in life
27. Thrombotic vascular risk factors in inflammatory bowel disease
28. Thromboembolism in inflammatory bowel disease: Role of platelets
29. Hemostatic abnormalities in inflammatory bowel disease
30. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease
31. Prevalence and significance of anticardiolipin antibodies in Crohn's disease
32. Free protein C deficiency in patients with Crohn's disease
33. Thrombosis in inflammatory bowel disease: Clinical setting, procoagulant profile and factor V Leiden
34. Factor V Leiden mutation is not increased in patients with inflammatory bowel disease
35. Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease
36. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease
37. Arg506Gln factor V mutation, and Va134Leu factor XIII polymorphism in Finnish patients with inflammatory bowel disease
38. Inflammatory bowel disease are not associated with major hereditary conditions predisposing to thrombosis
39. Thrombophilia and inflammatory bowel disease: Does factor V mutation have a role?
40. Factor V Leiden is not more frequent in inflammatory bowel disease
41. High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: A pathogenetic link with thromboembolic complications?
42. Sulphasalazine inhibits the absorption of folate in ulcerative colitis
43. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications
44. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with IBD
45. Homocysteine in inflammatory bowel disease: A risk factor for thromboembolic complications?
46. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer
47. The 677C 224 T mutation in 5,10-methylenetetrahydrofolate reductase and colorectal cancer risk